Provided by Tiger Trade Technology Pte. Ltd.

iShares U.S. Insurance ETF

137.10
-0.2350-0.17%
Volume:1K
Turnover:160.27K
Market Cap:418.14M
PE:34.92
High:137.10
Open:137.10
Low:137.10
Close:137.33
52wk High:152.38
52wk Low:124.62
Shares:3.05M
Float Shares:3.05M
Volume Ratio:0.17
T/O Rate:0.04%
Dividend:3.57
Dividend Rate:2.60%
EPS(TTM):3.93
ROE:--
ROA:--
PB:--
PE(LYR):- -

Loading ...

Allstate is Maintained at Outperform by Mizuho

Dow Jones
·
Sep 16

Chubb Ltd is Maintained at Neutral by Mizuho

Dow Jones
·
Sep 16

Japan Post Holdings Disposes of $1.59 Million in Aflac Common Shares

Reuters
·
Sep 16

Mizuho Securities Adjusts Chubb Price Target to $347 From $352, Maintains Neutral Rating

MT Newswires Live
·
Sep 16

Mizuho Securities Adjusts Allstate Price Target to $297 From $300, Maintains Outperform Rating

MT Newswires Live
·
Sep 16

Chubb price target lowered to $347 from $352 at Mizuho

TIPRANKS
·
Sep 16

Allstate price target lowered to $297 from $300 at Mizuho

TIPRANKS
·
Sep 16

CPIC Doubles Down on Catastrophe Risk Controls to Secure Full-Year Underwriting Profitability

Deep News
·
Sep 16

Lincoln National Corp. Stock Underperforms Tuesday When Compared to Competitors

Dow Jones
·
Sep 16

Press Release: Allstate Announces Preferred Dividends Payable Oct. 15, 2026

Dow Jones
·
Sep 16

How Catastrophe Insurance Can Serve as a Safety Net as Extreme Weather Becomes More Frequent

Deep News
·
Sep 15

Globe Life Inc. Stock Underperforms Monday When Compared to Competitors Despite Daily Gains

Dow Jones
·
Sep 15

Chubb Ltd. Stock Underperforms Monday When Compared to Competitors Despite Daily Gains

Dow Jones
·
Sep 15

Press Release: Travelers Schedules Conference Call to Review Third Quarter 2026 Results

Dow Jones
·
Sep 14

Japan Post Holdings Disposes of Aflac Shares Worth $1.52 Million

Reuters
·
Sep 14

Japan Post Holdings Disposes of 13,600 Aflac Shares Worth $1.57 Million

Reuters
·
Sep 10

Progressive (PGR) Receives a Hold from Morgan Stanley

TIPRANKS
·
Sep 10

CervoMed Announces Initial Results from the Phase 2a Clinical Trial of Neflamapimod in Nonfluent Variant Primary Progressive Aphasia (nfvPPA) Have Been Accepted as a Late-Breaking Oral Session at ISFTD 2026

GlobeNewswire
·
Sep 10

Bessent Warns of 'Socialist Hellscape' if Progressive Democrats Take Power

Dow Jones
·
Sep 10

Lincoln National Corp. Stock Underperforms Tuesday When Compared to Competitors

Dow Jones
·
Sep 09